摘要 |
FIELD: medicine.SUBSTANCE: invention represents a combination for treating breast cancer, containing the HSP90 inhibitor and HER2 inhibitor, wherein the HSP90 inhibitor represents ethylamide 5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid or its pharmaceutically acceptable salt, as well as a method of treating breast cancer, which involves administering an effective amount of this combination in a patient in need thereof.EFFECT: combination possesses the higher effectiveness as compared to its individual ingredients.6 cl, 1 ex, 1 tbl, 1 dwg |